Specialist in General Medicine
Institute for Orthomolecular Medicine
Lyngby, Denmark
Telephone: +45 88 09 00
Fax: +45 88 09 47
Email: ch@iom.dk
Address:
Claus Hancke, M.D.
Institute for Orthomolecular Medicine
Lyngby Hovedgade 37
DK-2800-Lyngby
Denmark
CERTIFICATIONS
Student exam. Mathematics/Physics, Gentofte / Copenhagen 1966.
Medical License: Jan.1974 from University of Copenhagen.
Physicians License: 1974.
License for General Practice: 1976.
Emergency Medicine: 1977.
Aviation Medicine: 1977.
ABCT Diplomate: 1990.
Specialist in General Medicine: 1994.
Educational Occupations (as junior physician)
| 1974 | Dermatology: Finsen Institute, Copenhagen, Denmark |
| 1974 | Surgery: Sundby Hospital, Copenhagen, Denmark |
| 1975-76 | Internal Medicine: Lycksele Lasarett, Sweden |
| 1976 | Psyciatrics: Umedalen, Umeå, Sweden |
| 1976 | Gyn./Obstetrics: Lycksele Lasarett, Sweden |
| 1977 | General Medicine: Rana Legesenter, Mo i Rana, Norway |
| 1977 | General Medicine: Lycksele Distriktslaekarcentral, Sweden |
| 1977-78 | Aviation Medicine: Vaerloese Air Base, Copenhagen, Denmark |
| 1978 | Rheumatology: Esboenderup Sygehus, North Sealand, Denmark |
Professional Occupations
| 1977 | Works Doctor, Burmeister & Wain Shipyard, Copenhagen |
| 1982-86 | Medical Consultant, County of Helsinge, North Sealand, Denmark |
| 1986-1996 | Army Medical Offc, HJV District North Sealand, Denmark |
| 1997-2007 | Army Medical Offc, HJV Region Copenhagen and North Sealand |
| 1979-1988 | General Practice (publ), Helsinge, North Sealand, Denmark |
| 1988–Present | Orthomolecular Practice, Kgs.Lyngby, Copenhagen |
SPECIAL COURSES
1976 Theoretical Medicine
1977 Emergency Medicine
1977 Aviation Medicine
1979 Column Diseases
1980 Diabetes
1981 Paediatrics
1981 Mycology
1982 Column Diseases
1983 Oncology
1983 Allergology
1984 Pain. Mechanism and coping
1984 Pulmonary Diseases (Teacher)
1985 Cardiology
1985 Endocrinology
1986 Preventive Medicine
1987 Lipid Metabolism
1987 Chelation therapy
1988 Chelation therapy
1990 Chelation therapy
1992 Chelation therapy
1993 Chelation therapy
1994 Chelation therapy
1995 Chelation therapy
1997 Chelation therapy
1997 Anti-Aging Medicine
1998 Anti-Aging Medicine
1998 Anti-Aging Medicine
1999 Chelation Therapy
2000 Mercury toxicity
2000 Anti-Aging Medicine
2000 Immunology
2001 Chelation Therapy
2001 Chelation Therapy
2002 Nutrition
2003 Nutrition
2003 Chelation Therapy
2004 Metal toxicology
2004 Nutrition
2005 Heavy metal toxicology
2005 Nutrition
2005 Endocrinologi
2006 I.V. therapies
2007 Heavy metal toxicology
2007 Chelation Therapy
2008 IV Therapies
2009 Detoxification
2011 Clinical Nutrition
2012 Oxidative Medicine
CONFERENCES
1986 Austria: General Medicine
1987 USA: Cellular Immunity, Damage and Repair
1988 USA: Orthomolecular Medicine
1990 USA: Immune Function and Dysfunction
1990 USA: Free Radicals in Health and Disease
1991 USA: Arteriosclerosis
1991 Italy: Free Radicals and Antioxidants
1992 USA: Chronic Fatigue
1992 Germany: Chelation Therapy (lecturer)
1993 USA: Duality of Oxygen in Health and Disease
1994 USA: Science in Clinical Practice
1994 USA: Lifestyle Medicine
1995 USA: Trends in Gender Related Healths Issues
1995 USA: Aging: Reducing, Reversing, Coping
1996 USA: Medical Challenges of the Next Millennium
1997 USA: Disorders in the Immune System
1997 Denmark: Health-Trends 2000, Longevity, (organiser and moderator)
1997 USA: Non-Pharmacological Intervention in Disease Managemet
1998 Canada: Nutrition Medicine today
1998 USA: Nutritional intervention in Cancer Prevention and Therapy
1999 USA: Exploring the Functions of the Brain: Solutions for Tomrorrow
1999 Denmark: Health-Trends 2000, Lifestyle Diseases, (organizer, moderator)
1999 USA: Cutting Edge Medicine. Optimizing Patient Outcomes
2000 USA: Medical Challenges for the Family
2000 USA: Infection, Inflammation, Immunity
2001 USA: New Advances in Complementary Medicine
2001 USA: Integrative Medicine
2002 USA: Integrative Medicine
2002 USA: Integrative Medicine
2002 London: 3rd International CoQ10 conference
2001 USA: New Advances in Complementary Medicine
2002 USA: New Advances in Complementary Medicine
2002 USA: New Advances in Complementary Medicine
2002 Denmark: Health-Trends 2002, Lifestyle Diseases, (organizer, moderator)
2002 England: 3. International Coenzym Q10 conference
2003 USA: Cancer. Complementary and conventional therapy
2003 USA : Neurological Diseases. Genetical- and Environmental Impact
2004 Germany: 2nd European Conf. of Advanced Clinical Metal Toxicology
2004 USA: Minerals, Metals and Metabolism
2004 USA: Emerging Concepts in Immunology
2005 USA: 2nd International Congress of Complementary Cancer Therapy
2005 USA: Menopause, Andropause: Power in Transition
2005 USA: New Research in Integrative Medicine
2006 USA: Chronic Infections, Lyme, Hidden Infections
2006 USA: Integrative Therapies for Neurological Disorders
2007 USA: Orthomolecular Medicine in the Future Patient Care
2007 USA: Integrative Medicine, Science and Clinical Practice
2008 USA: CAM Approaches to Cardiovascular Disease & Inflammation
2008 USA: Frontiers of Integrative Oncology
2009 USA: Detoxification
2011 USA: New Research in Integrative Medicine. Inflammation, Vit-D
2012 USA: Oxidative Medicine
PROFESSIONAL SOCIETIES
Danish Medical Association, 1974-
The Medical Society of Copenhagen, 1974-
Danish Society of General Medicine. 1979-
Danish Society of Manual Medicine, 1979-2002
Danish Society of Military Medicine, 1986-
American College for Advancement in Medicine, 1987-; Liaison/DK 1991-; Fellow 1998
American Board of Chelation Therapy, 1990-
International Board of Chelation Therapy, 1994-
Danish Society of Othomolecular Medicine, 1991-; Chair 1991-2002
American Preventive Medical Association, 1992-
Scandinavian Board of Clinical Metal Toxicology, 1995-; Chair 1995-
International Society for Orthomolecular Medicine, 1997-
Danish Society of Phyto-Medicine, 1999-
International Board of Chelation Therapy, 1994-
International Board of Clinical Metal Toxicology, 2004-
LECTURES
Emergency Medicine
Aviation Medicine
Free Radicals and Antioxidants
Preventive Medicine
Orthomolecular Medicine
Chelation Therapy
Redox treatment of cancer
Anti Aging
Human Nutrition
Medical Ethics
Health Politics
OTHER ASSIGNMENTS
| 1996-Present | Member of the Danish State Medical Advisory Board concerning Alternative Medicine |
| 1996-2000 | Member of the editorial board of Journal of Advancement in Medicine (Human Sciences Press, New York). |
| 2000-2004 | Member of the editorial board of Clinical Practise of Alternative Medicine |
| 2001-2003 | Member of the editorial board of Nordisk Tidsskrift for Biologisk Medisin |
| 2002-2011 | Chairman of “Vital Counsil” |
BIOGRAPHY
“The Descendants from Lars Hancke”. Gunnar Hancke 1983.
“The Danish Medical Society”, 15., 16. and 17.edition, Copenhagen 1982, 1993, 2000.
PUBLICATIONS
* = Peer Reviewed Medical Journal.
| 01)* | Hancke C. Curettage af vorter. Journal of the Danish Medical Association (Ugeskrift for Læger) 1974;136:1127-1131. |
| 02)* | Hansen JG, Knudsen JM, Hancke C. Alment praktiserende laeger og speciallaeger ser forskelligt på det – eller ser noget forskelligt. J Danish Med Ass 1983;145:1331-1332. |
| 03)* | Hornslet A, Hoffmann S, Backer P, Bentzen K, Clausen S, Hancke C. Hurtigdiagnostik af akutte luftvejsinfektioner i almen praksis. J Danish Med Ass 1988;150:1271-1274. |
| 04)* | Ahn NC, Hancke C. EDTA-behandling af arteriosclerose. J Danish Med Ass 1989;151:2599. |
| 05)* | Hancke C. Immune Function and Dysfunction:Scientific Perspectives and Clinical Applications. J Danish Med Ass 1990;152:2183. |
| 06) | Hancke C. Spild af tid og penge på forkert undersøgelse. Nyhedsinformation for Social- Sygehus- og Sundhedsvæsen 1990;5:4. |
| 07)* | Hancke C. Free Radicals: Understanding and Managing Their Impact on Health and Disease. J Danish Med Ass 1991;153:521. |
| 08) | Hancke C. EDTA virker. Teori & Terapi 1991;2:21. |
| 09)* | Hancke C. Lægestandens Koncensus. J Danish Med Ass 1991;153:3578. |
| 10) | Hancke C. Frie radikaler / antioxydanter: Kontrast mellem viden og brug. Non-pharm 1991;2/5:3. |
| 11)* | Flytlie K, Hancke C. Arteriosclerosis/Atherosclerosis: Assessment, Management, Reversal, Prevention. J Danish Med Ass 1992;154:1285. |
| 12) | Hancke C. EDTA igen. NaturMedicin 1992;6/4:1-2. |
| 13)* | Hancke C, Flytlie K. Manipulation med EDTA. J Danish Med Ass 1992;154:2213. |
| 14)* | Hancke C. EDTA som alternativ. J Danish Med Ass 1993;155:270. |
| 15)* | Flytlie K, Hancke C. EDTA Manipulated. Journal of Advancement in Medicine 1993;6:53-56(13). |
| 16)* | Flytlie K, Hancke C. Rezidiv- und Metastasen-profylaxe. J Danish Med Ass 1993;155:654. |
| 17)* | Hancke C, Flytlie K. Benefits of EDTA Chelation Therapy in Arteriosclerosis: A Retrospective Study of 470 Patients. Journal of Advancement in Medicine 1993;6/3:161-171. |
| 18)* | Hancke C. The Medical Consensus. Journal of Advancement in medicine 1993;6/3:193-194(9). |
| 19) | Hancke C. Myterne om det bedste sundhedsvæsen. Berl.Tid.21.01-94:9. |
| 20) | Hancke C. Må vi nu ikke spise gulerødder mere? Mit Helbred.1994;25:11 |
| 21) | Hancke C. Det syge væsen. Mit Helbred.1994;26:14-15. |
| 22)* | Hancke C. Vor træske stand. J Danish Med Ass 1994;156:5559. |
| 23) | Hancke C. Fri os for et Jernhelbred. Mit Helbred.1994;27:6-7. |
| 24) | Hancke C. Spis trygt dit blødkogte æg. Mit Helbred.1994;28:24-25. |
| 25) | Hancke C. Danish study of EDTA Chelation Reviewed by Committee on Scientific Dishonesty. Townsend Letter for Doctors 1994;Nov:1218-1223. |
| 26) | Hancke C. Oh hellige videnskab. Mit Helbred.1995;29:12-13. |
| 27)* | Feddersen S, Flytlie K, Hancke C. EDTA – En medicinsk løsning på et kirurgisk problem. J Danish Med Ass 1995;157:1224-1225. |
| 28) | Hancke C. Hvem tager håbet fra hvem? Mit Helbred.1995;30:26-27. |
| 29)* | Hancke C. G-ordningens farer. J Danish Med Ass 1995;157:1556. |
| 30)* | Hancke C. O Sancta Science or Simplicitas. Journal of Advancement in medicine 1995;8:201-3.(26). |
| 31) | Hancke C. Det ligner mad. Mit Helbred.1995;31:24-25. |
| 32)* | Hancke C. EDTA Manipulated. Journal of Advancement in medicine 1995;8/1:67-68. |
| 33)* | Hancke C. Nypuritanisme eller faglig kamp. J Danish Med Ass 1995;157:3070-1. |
| 34) | Hancke C. Cognitiv dissonans. Mit Helbred.1995;32:26-27. |
| 35)* | Chappell LT, Miranda R, Hancke C, Frackelton JP, Carter JP. EDTA chelation treatment for peripheral vascular disease. J Internal Medicine 1995;237:429-430. |
| 36) | Hancke C. Sundhedsvæsenet-et urørligt offentligt gebet. Mit Helbred. 1995;33:14-15. |
| 37) | Hancke C. Patientforeninger eller lamperøg? Mit Helbred.1995;34:14-15. |
| 38)* | Hancke C. Er vor art truet. J Danish Med Ass 1995;157/48:6756-8. |
| 39) | Hancke C. EDTA.Gamle fejl i fin ny emballage. Mit Helbred.1995;35:6-7. |
| 40) | Hancke C. Orthomolekylær medicin. Det 21.århundredes lægekunst. Mit Helbred.1995;36:15-16. |
| 41) | Hancke C. Spontan helbredelse. Mit Helbred.1996;1:6-7. |
| 42) | Hancke C. Der er vist nogen, der har mistet overblikket. Mit Helbred.1996;1:20-1. |
| 43) | Hancke C. Vær på vagt over for sidste nyt i sundhedsråd. Berl.Tid.12/3-96. |
| 44) | Hancke C. Ny stænkelap-sag. Mit Helbred. 1996; 2: 12-3. |
| 45) | Hancke C. Som man råber i skoven. Mit Helbred. 1996; 3:12. |
| 46) | Hancke C. Nye ideer til lægerne. Politiken.18/5-96;2.sek.3. |
| 47) | Hancke C. Lægevidenskab eller lægekunst. Mit Helbred. 1996;4:6-7. |
| 48) | Hancke C. Yam.(Osteoporosis). Mit Helbred. 1996;5:6-7. |
| 49) | Hancke C. Ligemageriets pris er middelmådighed.Mit Helbred.1996; 6:14-5. |
| 50) | Hancke C. Hvorfor taler vi om kræftens gåde? Mit Helbred.1996; 7:10-12. |
| 51) | Hancke C. Lad os få ODA i stedet for RDA og ADT. Mit Helbred.1997;1: 2-3 (Editorial). |
| 52)* | Feddersen S, Flytlie K, Hancke C. EDTA-chelation. En medicinsk behand-ling og et kirurgisk problem. J Danish Med Ass 1997;159/21:3196-7. |
| 53) | Hancke C. Lægelige kostråd tages med et gran salt. Diætisten 1998;6/32:22-25. |
| 54) | Hancke C. Medicinsk kelering – ekologisk medicin på cellnivå. Näringsråd och Näringsrön (Götheborg). 1997;2/6:6-7. |
| 55) | Hancke C. Må vi nu ikke spise appelsiner mere? Mit Helbred.1998;3:6. |
| 56)* | Gad P, Hancke C. Alternative læger findes ikke. J Danish Med Ass 1999;161/40:5584-5586. |
| 57) | Hancke C. Sundhedsvæsenets fremtid er en blind vej. Mit Helbred.1999;7/8:61-61. |
| 58)* | Hancke C. The Long-term Effect of Chelation Therapy: A 6- to 12-year Follow up of a 1993 EDTA Study. Clin Pract Alt Med spring 2000, 1(3):158-163. |
| 59)* | Hancke C. Korrespondance. J Danish Med Ass 2001; 163/15:2172. |
| 60) | Hancke C. De rette molekylers medicin. Dagens Medicin 290301. |
| 61) | Hancke C. Får vi vitaminer og mineraler nok i en dansk normalkost? Lægemagasinet for Praktiserende Læger. 2001;6:18-19. |
| 62) | Hancke C. EDTA-kelering. Kliniska erfarenheter av kärlsjukdomer. Näringsråd och Näringsrön 2001;6(6):1-4. |
| 63)* | Hancke C. Magnesium-EDTA-chelationbehandling. Praktikus, 1. november, 2002. |
| 64)* | Hancke C. Third Conference of the International Coenzyme Q10 Association. J Danish Med Ass 2003;165/8:816-7. |
| 65)* | Andersen P, Hancke C. Mødereferat, USA. J Danish Med Ass 2003;165/35: 3330-1. |
| 66)* | Hancke C. Kosttilskud bør tages alvorligt. J Danish Med Ass 2003;165/39:3747. |
| 67)* | Hancke C. Magnesium-EDTA chelationsbehandling. Fremtidens first choice ved arteriosclerose. Praktikus 2003;160:56-7. |
| 68) | Skovgaard L. Lægekunst i det 21.århundrede. Hovedland 2003, ISBN: 8777396707:19-33. Orthomolekylær Medicin. |
| 69)* | Chappell LT, Shukla R, Hancke C et al. Subsequent Cardiac and Stroke Events in Patients with Known Vascular Disease Treated with EDTA Chelation Therapy. Evid Based Integrative Med 2005;2(1): 27-35. |
| 70) | Skovgaard L. Sund Skepsis. Hovedland 2006, ISBN:8777398564:10-25. Antibiotika. |
| 71) | DSOM homage ”20 år mod strømmen”. Editor and article. 2009. Bording. |
| 72) | Bidsted O. Sundhedsvæsen eller Medicinindustri. Klitrosen 2010, ISBN:87-92041-14-0. ”Kættersk behandling af Åreforkalning.” |
| 73) | Skovgaard L. Sund Skepsis og Sund Fornuft. 2010, ISBN:978-87-7070-165-5. Antibiotika. |